Characterization of Nanobody Binding to Distinct Regions of the SARS-CoV-2 Spike Protein by Flow Virometry
Nanobodies, or single-domain antibodies (V<sub>H</sub>Hs) from camelid heavy-chain-only antibodies, offer significant advantages in therapeutic and diagnostic applications due to their small size and ability to bind cryptic protein epitopes inaccessible to conventional antibodies. In thi...
Saved in:
| Main Authors: | Mariam Maltseva, Martin A. Rossotti, Jamshid Tanha, Marc-André Langlois |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Viruses |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4915/17/4/571 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Broad‐Spectrum Engineered Multivalent Nanobodies Against SARS‐CoV‐1/2
by: Zhihong Wang, et al.
Published: (2024-12-01) -
From immune evasion to broad in silico binding: computational optimization of SARS-CoV-2 RBD-targeting nanobody
by: Shuyuan Cao, et al.
Published: (2025-08-01) -
Computational electrostatic engineering of nanobodies for enhanced SARS−CoV−2 receptor binding domain recognition
by: Zafar Iqbal, et al.
Published: (2025-03-01) -
Nanobodies: From Discovery to AI-Driven Design
by: Haoran Zhu, et al.
Published: (2025-05-01) -
The Use of Heterologous Antigens for Biopanning Enables the Selection of Broadly Neutralizing Nanobodies Against SARS-CoV-2
by: Vazirbek S. Aripov, et al.
Published: (2025-03-01)